A phase IIa, multicenter, randomized, two-arm, observer-blind, vehicle and reference controlled proof of concept trial to investigate intra-individually (left/ right) the antipsoriatic efficacy and safety of once daily topical application of Valrubicin cream 1 % in comparison to vehicle and reference product in adult patients with stable plaque psoriasis.
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2013
At a glance
- Drugs Valrubicin (Primary) ; Calcipotriol
- Indications Plaque psoriasis
- Focus Biomarker; Therapeutic Use
- 19 Jul 2011 New trial record